These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 24641800

  • 21. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
    Shimoda M, Mori S, Kita J, Sawada T, Kubota K.
    Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
    [Abstract] [Full Text] [Related]

  • 22. Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection.
    Eguchi H, Ishikawa O, Ohigashi H, Takahashi H, Ohue M, Takenaka A, Tomita Y, Yano M.
    Am J Surg; 2009 Nov; 198(5):e66-71. PubMed ID: 19887180
    [Abstract] [Full Text] [Related]

  • 23. Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters.
    Kim M, Kang TW, Cha DI, Kim YK, Kim SH, Jang KT, Han IW, Sohn I.
    Clin Radiol; 2018 Jun; 73(6):564-573. PubMed ID: 29519500
    [Abstract] [Full Text] [Related]

  • 24. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM, Croagh D, Coldham C, Tanière P, Buckels J, Isaac J, Mayer D, Muiesan P, Bramhall S, Mirza DF.
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [Abstract] [Full Text] [Related]

  • 25. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K.
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [Abstract] [Full Text] [Related]

  • 26. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW, Wu WD, Xiao WD, Li HW, Peng CH.
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [Abstract] [Full Text] [Related]

  • 27. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head.
    Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, de Wit LT, Verbeek PC, Gouma DJ.
    Br J Surg; 1994 Nov; 81(11):1642-6. PubMed ID: 7827892
    [Abstract] [Full Text] [Related]

  • 28. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F, Gill AJ, Neale M, Puttaswamy V, Gananadha S, Pavlakis N, Clarke S, Hugh TJ, Samra JS.
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [Abstract] [Full Text] [Related]

  • 29. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Nagakawa Y, Jang JY, Kawai M, Kim SC, Inoue Y, Matsuyama R, Heo JS, Honda M, Sugiura T, Ohtsuka M, Mizuno S, Kwon W, Uemura K, Han HS, Sugimoto M, Okano K, Nakamura M, Wada K, Kumamoto Y, Osakae H, Tsuchida A, Yoon YS, Park JS, Yamaue H, Endo I.
    Ann Surg; 2023 May 01; 277(5):e1081-e1088. PubMed ID: 34913900
    [Abstract] [Full Text] [Related]

  • 30. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.
    Fujii T, Nakao A, Yamada S, Suenaga M, Hattori M, Takami H, Inokawa Y, Kanda M, Sugimoto H, Nomoto S, Murotani K, Kodera Y.
    Surgery; 2015 Apr 01; 157(4):708-15. PubMed ID: 25704426
    [Abstract] [Full Text] [Related]

  • 31. Histopathologic tumor invasion of superior mesenteric vein/ portal vein is a poor prognostic indicator in patients with pancreatic ductal adenocarcinoma: results from a systematic review and meta-analysis.
    Song A, Liu F, Wu L, Si X, Zhou Y.
    Oncotarget; 2017 May 16; 8(20):32600-32607. PubMed ID: 28427231
    [Abstract] [Full Text] [Related]

  • 32. Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.
    Onoe S, Kaneoka Y, Maeda A, Takayama Y, Fukami Y.
    Langenbecks Arch Surg; 2017 May 16; 402(3):439-446. PubMed ID: 28246964
    [Abstract] [Full Text] [Related]

  • 33. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
    Chu CK, Farnell MB, Nguyen JH, Stauffer JA, Kooby DA, Sclabas GM, Sarmiento JM.
    J Am Coll Surg; 2010 Sep 16; 211(3):316-24. PubMed ID: 20800187
    [Abstract] [Full Text] [Related]

  • 34. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
    Yu XZ, Li J, Fu DL, Di Y, Yang F, Hao SJ, Jin C.
    Eur J Surg Oncol; 2014 Apr 16; 40(4):371-8. PubMed ID: 24560302
    [Abstract] [Full Text] [Related]

  • 35. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S, Oussoultzoglou E, Bachellier P, Rosso E, Nakano H, Audet M, Jaeck D.
    Arch Surg; 2007 Feb 16; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [Abstract] [Full Text] [Related]

  • 36. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
    Groen JV, van Manen L, van Roessel S, van Dam JL, Bonsing BA, Doukas M, van Eijck CHJ, Farina Sarasqueta A, Putter H, Vahrmeijer AL, Verheij J, Besselink MG, Groot Koerkamp B, Mieog JSD.
    Pancreas; 2021 Sep 01; 50(8):1218-1229. PubMed ID: 34714287
    [Abstract] [Full Text] [Related]

  • 37. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
    Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB.
    Br J Surg; 1998 May 01; 85(5):611-7. PubMed ID: 9635805
    [Abstract] [Full Text] [Related]

  • 38. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH.
    J Gastrointest Surg; 2014 Feb 01; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [Abstract] [Full Text] [Related]

  • 39. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Wakamatsu S, Hoshi S, Hoshi N, Hirabayashi K, Ogata Y.
    Eur J Surg Oncol; 2017 Jun 01; 43(6):1068-1075. PubMed ID: 28427822
    [Abstract] [Full Text] [Related]

  • 40. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Autret A, Turrini O, Monges-Ranchin G, Boher JM.
    HPB (Oxford); 2014 Jan 01; 16(1):20-33. PubMed ID: 23464850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.